XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable Accounts Receivable
In millionsJune 30,
2024		December 31,
2023
Trade accounts receivable, gross$651 $741 
Allowance for credit losses(10)(7)
Total accounts receivable, net$641 $734 
Schedule of Inventory
Inventory
In millionsJune 30,
2024		December 31,
2023
Raw materials$232 $276 
Work in process416 402 
Finished goods35 30 
Inventory, gross683 708 
Inventory reserve(122)(121)
Total inventory, net$561 $587 
Schedule of Accrued Liabilities
Accrued Liabilities
In millionsJune 30,
2024		December 31,
2023
Legal contingencies(1)
$481 $484 
Contract liabilities, current portion238 252 
Accrued compensation expenses
197 223 
Accrued taxes payable177 79 
Operating lease liabilities, current portion71 86 
Liability-classified equity incentive awards— 55 
Other, including warranties(2)
101 146 
Total accrued liabilities$1,265 $1,325 
_____________
(1)See note 8. Legal Proceedings for additional details.
(2)See table below for changes in the reserve for product warranties.
Schedule of Changes in Reserve for Product Warranties
Changes in the reserve for product warranties were as follows:
In millionsQ2 2024Q2 2023YTD 2024YTD 2023
Balance at beginning of period$20 $19 $21 $18 
Additions charged to cost of product revenue10 11 22 20 
Repairs and replacements(13)(10)(26)(18)
Balance at end of period$17 $20 $17 $20 
Schedule Of Restructuring and Related Costs
A summary of the pre-tax restructuring charges are as follows:

In millions
Q2 2024
Q2 2023
YTD 2024
YTD 2023
Cumulative charges recorded since inception
Employee separation costs$3 $25 $7 $25 $55 
Asset impairment charges(1)
— 7 32 7 132 
Other costs1 1 1 1 5 
Total restructuring charges(2)
$4 $33 $40 $33 $192 
_____________
(1)For YTD 2024, charges primarily relate to impairment of right-of-use assets and leasehold improvements for our Foster City campus. Cumulative charges recorded since inception also include impairment of right-of-use assets and leasehold improvements for our i3 campus.
(2)For Q2 2024, $4 million was recorded in SG&A expense. For YTD 2024, $39 million was recorded in SG&A and $1 million in R&D expense.
For Q2 2023 and YTD 2023, $18 million was recorded in SG&A expense, $12 million in R&D expense, and remainder in cost of revenue.
A summary of the restructuring liability is as follows:

In millions
Employee Separation Costs(1)
Other CostsTotal
Amount recorded in accrued liabilities as of December 31, 2023
$17 $1 $18 
Additional expense recorded
7 1 8 
Cash payments
(19)(2)(21)
Adjustments to accrual
(2)— (2)
Amount recorded in accrued liabilities as of June 30, 2024
$3 $— $3 
_____________
(1)It is expected that substantially all of the employee separation related restructuring charges will be paid by the end of Q3 2024.
Schedule of Goodwill
Changes to goodwill during YTD 2024 were as follows:
In millions
Balance as of December 31, 2023(1)
$2,545 
Impairment
(1,466)
Balance as of June 30, 2024
$1,079 
_____________
(1)The balance as of December 31, 2023 includes accumulated impairment of $4,626 million related to our GRAIL reporting unit.
Schedule of Finite-Lived Intangible Assets
The following is a summary of our identifiable intangible assets:
 June 30, 2024December 31, 2023
In millionsGross
Carrying
Amount		Accumulated
Amortization		Intangible Assets,
Net		Gross
Carrying
Amount		Accumulated
Amortization
Impairment
Intangible Assets,
Net
Developed technologies$424 $(289)$135 $2,807 $(585)$— $2,222 
Licensed technologies274 (147)127 274 (133)— 141 
Trade name3 (3)— 43 (14)— 29 
Customer relationships14 (13)1 14 (13)— 1 
License agreements20 (13)7 14 (13)— 1 
Database12 (4)8 12 (3)— 9 
Total finite-lived intangible assets, net747 (469)278 3,164 (761)— 2,403 
In-process research and development (IPR&D)— — — 705 — (115)590 
Total intangible assets, net$747 $(469)$278 $3,869 $(761)$(115)$2,993 
Schedule of Indefinite-Lived Intangible Assets
The following is a summary of our identifiable intangible assets:
 June 30, 2024December 31, 2023
In millionsGross
Carrying
Amount		Accumulated
Amortization		Intangible Assets,
Net		Gross
Carrying
Amount		Accumulated
Amortization
Impairment
Intangible Assets,
Net
Developed technologies$424 $(289)$135 $2,807 $(585)$— $2,222 
Licensed technologies274 (147)127 274 (133)— 141 
Trade name3 (3)— 43 (14)— 29 
Customer relationships14 (13)1 14 (13)— 1 
License agreements20 (13)7 14 (13)— 1 
Database12 (4)8 12 (3)— 9 
Total finite-lived intangible assets, net747 (469)278 3,164 (761)— 2,403 
In-process research and development (IPR&D)— — — 705 — (115)590 
Total intangible assets, net$747 $(469)$278 $3,869 $(761)$(115)$2,993 
Schedule of Estimated Annual Amortization of Finite-lived Intangible Assets The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.
In millionsEstimated Annual Amortization
2024 (remainder of year)
$31 
202562 
202650 
202748 
202845 
Thereafter42 
Total$278